Financials
| Full Year 2025 Trading Update | Jan. 15, 2026 |
| H1 2025 Results | Sep. 23, 2025 |
| 22% Revenue Growth H125 representing 3-yr CAGR 25% | Jul. 22, 2025 |
| FY 2024 Results - Strong Revenue Growth | May. 13, 2025 |
| FY 2024 Trading Update - Strong Revenue Growth | Jan. 28, 2025 |
| H1 2024 Results - Continued Performance & Growth | Sep. 17, 2024 |
| Revenue growth of 24% in H1 with 55% now recurring | Jul. 23, 2024 |
Proxies
| Results of AGM | Jun. 18, 2025 |
| Notice of AGM and Posting of Annual Report | May. 21, 2025 |
| Result of AGM | Jun. 24, 2024 |
| Notice of AGM and Posting of Annual Report | May. 29, 2024 |
| Results of Annual General Meeting | May. 18, 2023 |
| Notice of AGM and Posting of Annual Report | Apr. 25, 2023 |
| Result of AGM | May. 26, 2022 |
Ownership Update
| PDMR Shareholding/Share Incentive Plan and TVRs | Mar. 03, 2026 |
| PDMR Shareholding/SIP & Total Voting Rights | Dec. 23, 2025 |
| PDMR Shareholding/Share Incentive Plan and TVR | Oct. 01, 2025 |
| Holding(s) in Company | Sep. 09, 2025 |
| PDMR Shareholding/Share Incentive Plan and TVR | Sep. 02, 2025 |
| Holding(s) in Company | Aug. 11, 2025 |
| Issue of Share Options / PDMR Shareholdings | Jul. 23, 2025 |
Announcements
| PDMR Shareholding/SIP & Total Voting Rights | Nov. 28, 2025 |
| Block listing Interim Review | Oct. 07, 2025 |
| Notice of Results | Sep. 11, 2025 |
| Diaceutics at Canaccord Genuity Growth Conference | Aug. 05, 2025 |
| PDMR Shareholding/Share Incentive Plan and TVR | Jul. 30, 2025 |
| Diaceutics Announces Key Leadership Appointment | Jul. 29, 2025 |
| Expansion of PMx Commercialization Partnership | Jul. 17, 2025 |